Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Multigene Expression Classification of Neuroblastoma Patients

NCT00958659 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00958659
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00958659 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Multigene Expression Classification of Neuroblastoma Patients
Lead sponsor
Children's Oncology Group
Phase
Observational
Overall status
Completed
Start date
December 31, 2008
Completion date
May 31, 2016
Enrollment
350 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

localized resectable neuroblastoma, localized unresectable neuroblastoma, regional neuroblastoma, stage 4s neuroblastoma